CytoSorbents Corporation (CTSO)

[pearsby09]

Hello Cars, nice to hear from you and I hope you are doing well. I like the fact that Chan has bought more in the open market. That speaks volumes to a CEO's confidence moving forward. I also think profitability is within a two year window. However, the R1 Hemoglobin data will be a dud to Wall Street..Trust me! A surrogate marker in a small preliminary trial will have little to No impact. CTSO has a Long Long Road ahead of them with R2, 3 years out to prove POC in the cardiology arena! This has already been proven by the sepsis surrogate Debacle. I do think QoQ will be good in 2017 and if you can buy at 4.80 or less, you should garner a decent ROI! Your..Beloved..Pearsby